Bioscience Bulletin
Bioscience Bulletin – December 12, 2025
G2G was on Capitol Hill this week and met with Senate Health Education Labor & Pensions (HELP) Committee Chair Bill Cassidy (R-LA), and the offices of House Speaker Mike Johnson (R-LA) and Energy & Commerce Health Subcommittee Chair Morgan Griffith (R-VA) to advocate for the National Plan for Epilepsy Act.
Read MoreBioscience Bulletin – December 5, 2025
Federal Legislative Updates Ohio Legislative Updates G2G Blog Bioscience Bulletin – December 5, 2025 Back to All Posts G2G Highlights G2G was on Capitol Hill on Monday and Tuesday with Women’s…
Read MoreBioscience Bulletin – Nov 21, 2025
G2G had the privilege to be participant and organizing partner at Friday’s Empowering the Future of Biotechnology Through Trusted Science event hosted by ATCC.
Read MoreBioscience Bulletin – Nov 14, 2025
On Monday, G2G Founder & CEO, Liz Powell was among the women’s health leaders at the Department of Health & Human Services (HHS) where Secretary Kennedy and FDA Director Marty Makary, announced that hormone replacement therapy (HRT) products for perimenopause and menopause would no longer need to carry black box warnings.
Read MoreBioscience Bulletin – Nov 9, 2025
Last week was an active week for health policy! Our Founder and CEO, Liz Powell, Esq., MPH attended the Milken Institute Future of Health Summit, in Washington, D.C.. She participated in the
Read MoreBioscience Bulletin
The shutdown that began on October 1 continues with no end in sight. Most Congressional Democrats refuse to support a bill to re-open the government without an extension of the Affordable Care Act subsidies, which is supported by 78% of the public according to polling by KFF.
Read More